Should doctors discourage nutritional supplementation? A cardiovascular perspective

Heart Lung and Circulation

Volumn 13, Issue 3, 2004, Pages 245-251

  Lewis, Gerald R J ^a  

^a NONE   (New Zealand)

Author keywords

Antioxidant; Cardiovascular disease; Coronary disease; Nutrition; Supplementation

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; ANTIOXIDANT; ASCORBIC ACID; BETA TOCOPHEROL; DELTA TOCOPHEROL; FISH OIL; FOLIC ACID; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRON; LINOLEIC ACID; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MINERAL; MONOUNSATURATED FATTY ACID; MULTIVITAMIN; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; POTASSIUM; RETINOL; SELENIUM; SODIUM CHLORIDE; UNINDEXED DRUG; VITAMIN;

ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL STUDY; CLINICAL TRIAL; DRUG EFFICACY; DRUG POTENTIATION; HEART PROTECTION; HUMAN; LIFESTYLE; LIPID OXIDATION; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SELENIUM DEFICIENCY; SUPPLEMENTATION;

EID: 4844220502     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2004.06.012     Document Type: Review

References (48)

1. Vivekananthian DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomized trials. Lancet 2003;361:2017-23.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
3. US Senate Document No. 264 and the Earth Summit Report 1999.
4. Strong JP, Malcome GT, McMahon CA, Tracy RE, Newman WP, Herderict EE, et al. Prevalence and extent of atherosclerosis in adolescent and young adults. Implications for prevention for the pathobiological determinants of atherosclerosis in youth study. JAMA 1999;281:727-35.
5. Steinberg D, Parsatharithy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol, modifications of low density lipoprotein that increase its atherogenicity. N Eng J Med 1989;320:915-24.
6. Evans T. Cardiac arrests outside hospital. BMJ 1998;316:1031-2 (Editorial).
7. Chan AC. Partners in defense, Vitamin E and Vitamin C. Can J Physiol Pharmacol 1993;71:725-31.
8. Houston MC. The role of antioxidants in the prevention and treatment of coronary artery disease. JAMA 2003;6(2):17-23.
9. Boaz M, Smetana S, et al. Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE): randomized placebo controlled trial. Lancet 2000;356:1213-8.
10. Simons LA, Von Konigsmark M, Balasubrimanian S. What dose of Vitamin E is required to reduce susceptibility of LDL to oxidation? Aust NZ J Med 1996;26:496-502.
11. Kazdova L. Protective effect of Vitamin E on aortic lipid peroxidation and atheroma formation in hypercholesterolaemic rabbits. Atherosclerosis 1995;115:S47.
12. Keegan A, Walbank H, Cotter MA, Cameron NE. Chronic Vitamin E treatment prevents defective endothelium relaxation in diabetic rat aorta. Diabetologia 1995;38:1475-8.
13. Verlangieri AJ, Bush MJ. Effects of D-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992;11:131.
14. Stampfer MJ, Hennekens M, et al. Vitamin E consumption and the risk of coronary artery disease in women. N Eng J Med 1993;328:1444-9.
15. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in post menopausal women. N Eng J Med 1996;336(18):1156-62.
16. Rimm EB, Stampfer MJ, Ascherio A, Giovannucia E, Colditz GA, Willet WC. Vitamin E consumption and the risk of coronary heart disease in men. N Eng J Med 1993;328:1450-6.
17. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and Vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons. Am J Clin Nutr 1996;64:190-6.
18. de Gactano G. Low dose aspirin and Vitamin E in people at cardiovascular risk, a trial in general practice. Collaborative group of the Primary Preventive Project. Lancet 2001;357:89-95.
19. A randomized placebo controlled, clinical trial of high dose supplementation with Vitamins C, E and beta carotene for age related cataract and vision loss. Arch Ophthalmol 2001;119:1439-52.
20. The effect of Vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Eng J Med 1994;330:1029-35.
21. Yusef S, Dagenaga G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high risk patients. The heart Outcomes Prevention Evaluation Study Investigators. N Eng J Med 2000;342:154-60.
22. Dietary supplementation with n-3 polyunsaturated fatty acids and Vitamin E after myocardial infarction: results of the GISSI Prevenzione trial. Lancet 1999;354:447-55.
23. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high risk individuals: a randomized placebo controlled trial. Lancet 2002;360:23-33.
24. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised control trial of Vitamin E in patients with coronary disease, Cambridge heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
25. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, et, al. Effects of Vitamin C and E on progression of transplant associated atherosclerosis: a randomized trial. Lancet 2002;359:1108-11.
26. Nyyssonen K, Parviainen MT. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997;314:634-8.
27. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Hu FB, Manson JE, et al. Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiolk 2003;42(2):253-5.
28. Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA 2002;287:3127-9.
29. Rimm EB, Willett WC, et al. Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease in women. JAMA 1998;279:359-64.
30. Stampfer MJ, Hennekens CH, Manson JE, Coditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary heart disease in women. N Eng J Med 1993;328:1444-9.
31. Dyckner T, Wester PO. Magnesium in cardiology. Acta Med Scand 1982;661(Suppl):27-31.
32. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality: meta analysis of magnesium in acute myocardial infarction. Circulation 1992;86:774-9.
33. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester intravenous magnesium intervention trial (LIMIT-2). Lancet 1992;339:1553-8.
34. The National Health and Nutritional Examination survey epidemiological follow up study. Int J Epidemiol 1999;28:645-51.
35. Ford ES. Serum magnesium and ischaemic heart disease: findings from a national sample of US adults. Int J Epidemiol 1999;28:645-51.
36. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, et al. Dietary magnesium intake and the future risk of coronary heart disease (The Honolulu Heart Program). Am J Cardiol Sep 2003;92(6):665-9.
37. Robinson MF. Selenium in human nutrition in New Zealand. Nutr Rev 1989;47:99-107.
38. Clark L, Combs G, et al. Effects of Selenium Supplementation for Cancer Prevention in Patients with Carcinoma of the Skin. J Am Med Assoc 1996;276:1957-62.
39. Dyerberg J, Bang HO, Stofferson E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis. Lancet 1978;ii:117-9.
40. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287(14):1815-21.
41. Burr ML, Fehily AM, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989;2(8666):757-61.
42. Ascherio A, Rimm EB, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. NEJM 1995;332:977-83.
43. Daviglus ML, Stamle J, Orencia AJ, Dyer AR, Liu K, Greenland P, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. NEJM 1997;336:1046-53.
44. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Dietary supplementation with n-3 polyunsaturated fatty acids and Vitamin E after myocardial infarction: results of [Gruppo Italiano per lo Studio della Soprav-vivenze nell'infarto] GISSI-Prevenzione. Lancet 1999;354:447-55.
45. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. NEJM 2002;346:1113-8.
46. Siscovick DS, Raghunathan TE. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1996;275(11):836-7.
47. Coombes JS, Gore P. Antioxidants, exercise and Australian and New Zealand cardiologists. Int Med J 2001;31:501-4.
48. Meta J. Antioxidants among American cardiologists. Am J Cardiol 1997;79:1558-60.